Demir M - Search Results

1

Evaluation of the Practice Pattern of Medical Patients' VTE Prophylaxis With a Standard Risk Assessment Model Form: MERAM Study.

Ongen G, Demir M, Molinas N, Ince B, Ongen Z. Ongen G, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2015 Jul;21(5):412-9. doi: 10.1177/1076029613505765. Epub 2013 Oct 10. Clin Appl Thromb Hemost. 2015. PMID: 24113493 Free article.

2

Oxidative stress and total antioxidant capacity in diabetic and nondiabetic acute ischemic stroke patients.

Guldiken B, Demir M, Guldiken S, Turgut N, Turgut B, Tugrul A. Guldiken B, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2009 Dec;15(6):695-700. doi: 10.1177/1076029608323087. Epub 2008 Oct 7. Clin Appl Thromb Hemost. 2009. PMID: 18840626 Free article.

3

Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations.

Turgut N, Akdemir O, Turgut B, Demir M, Ekuklu G, Vural O, Ozbay G, Utku U. Turgut N, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2006 Jan;12(1):15-20. doi: 10.1177/107602960601200104. Clin Appl Thromb Hemost. 2006. PMID: 16444430 Free article.

4

Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.

Ermantas N, Guldiken S, Demir M, Tugrul A. Ermantas N, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2010 Oct;16(5):568-73. doi: 10.1177/1076029609350890. Epub 2009 Dec 2. Clin Appl Thromb Hemost. 2010. PMID: 19959491 Free article.

5

Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor.

Gül C, Kürüm T, Demir M, Ozbay G, Vural O, Iqbal O, Fareed J. Gül C, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2004 Jan;10(1):77-9. doi: 10.1177/107602960401000114. Clin Appl Thromb Hemost. 2004. PMID: 14979411 Free article.

6

The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus.

Guldiken S, Turgut B, Demir M, Arikan E, Kara M, Vural O, Tugrul A, Fareed J. Guldiken S, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2006 Jan;12(1):55-60. doi: 10.1177/107602960601200109. Clin Appl Thromb Hemost. 2006. PMID: 16444435 Free article. Clinical Trial.

7

Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke.

Duran R, Biner B, Demir M, Celtik C, Karasalihoğlu S. Duran R, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2005 Jan;11(1):83-8. doi: 10.1177/107602960501100110. Clin Appl Thromb Hemost. 2005. PMID: 15678277 Free article.

8

Correlation between maternal plasma thrombomodulin and infant birth weight in hypertensive disorders of pregnancy.

Varol FG, Ozgen L, Sayin NC, Demir M. Varol FG, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2009 Mar-Apr;15(2):166-70. doi: 10.1177/1076029608325543. Epub 2008 Nov 19. Clin Appl Thromb Hemost. 2009. PMID: 19022800 Free article.

9

Pitfalls in the diagnosis of immune thrombocytopenic purpura in children: 4 case reports.

Biner B, Devecioğlu O, Demir M. Biner B, et al. Among authors: demir m. Clin Appl Thromb Hemost. 2007 Jul;13(3):329-33. doi: 10.1177/1076029607302444. Clin Appl Thromb Hemost. 2007. PMID: 17636197 Free article.

10

Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.

Demir M, Duran E, Yigitbasi O, Vural O, Kurum T, Yuksel M, Turgut B, Walenga JM, Fareed J. Demir M, et al. Clin Appl Thromb Hemost. 2007 Jul;13(3):279-84. doi: 10.1177/1076029607299987. Clin Appl Thromb Hemost. 2007. PMID: 17636189 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,464 results

Search Page

Filters